Novo's Wegovy pill tracks over 26,000 prescriptions

Core Insights - Novo Nordisk's Wegovy pill achieved over 26,000 prescriptions in the U.S. during the second full week following its launch, indicating strong initial demand for the product [1] Group 1 - Wegovy's prescription numbers reflect a significant uptake in the market, showcasing the potential for growth in the obesity treatment sector [1]